} ?>
On December 13, GF CSI All-Index Medical and Health ETF (159938) closed down 2.15%, with a turnover of 34.3805 million yuan.
159938Established on December 1, 2014, the full name of the fund is GF CSI All-Index Medical and Health Exchange-traded Open-ended Index Securities Investment Fund, and the fund is referred to as GF CSI All-Index Medical and Health ETF. The fund has a management fee of 0.50% per annum and a custody fee of 0.10% per annum. The performance of the Healthcare ETF (159938) is benchmarked against the CSI All-Index Healthcare Index.
In terms of scale, as of December 12, the latest share of the medical and health ETF (159938) was 7.585 billion shares, and the latest scale was 4.944 billion yuan. Looking back on December 29, 2023, the share of the medical and health ETF (159938) was 7.587 billion, with a scale of 5.306 billion yuan. That is, the share of the fund has decreased by 0.03% and the scale has decreased by 6.82% since the beginning of this year.
In terms of liquidity, as of December 13, the cumulative turnover of medical and health ETF (159938) in the past 20 trading days was 831 million yuan, with an average daily turnover of 41.529 million yuan, and since the beginning of this year, the cumulative turnover in 230 trading days has been 10.574 billion yuan, with an average daily turnover of 45.976 million yuan.
The current fund manager of the Healthcare ETF (159938) is Huo Huaming. Hovamin has managed (or intends to manage) the fund since April 20, 2017, with a return of -0.46% during his tenure.
According to the latest regular report, the heavy stocks of the pharmaceutical and health ETF (159938) include Hengrui Pharmaceutical, Mindray Medical, WuXi AppTec, Pien Tze Huang, Aier Ophthalmology, Yunnan Baiyao, United Imaging Medical, NHU, Shanghai RAAS, and Zhifei Biotech, with the following proportions.
stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
600276 | Hengrui Pharmaceutical | : 9.68%, | 9.628 million | , 504 million |
, 300760 | ,Mindray Medical | , 7.37%, | 1.3078 million | , 383 million |
603259 | WuXi AppTec | 5.49% | 5.449 million | 285 million |
600436 | Pien Tze Huang | 3.23% | 650,600 | 168 million |
300015 | Aier Ophthalmology | 3.08% | 10,064,800,160 | million |
000538 | Yunnan Baiyao | 2.26% | 1,923,990,117 | million |
688271 | United Imaging Medical | 1.75% | 711,590,999,000||
002001 | Xinhecheng | 1.74% | 4,001,490,312,100 | |
002252 | Shanghai RAAS | 1.74%, | 11.4697 million | , 90.611 million |
300122 | Zhifei Biotech | 1.66%, | 2.5823 million | , 66.1956 million |
Risk Warning: The market is risky, and investment needs to be cautious. This article is automatically released by the AI model, and any information appearing in this article (including but not limited to individual stocks, comments, forecasts, charts, indicators, theories, any form of expression, etc.) is for reference only and does not constitute personal investment advice. The MACD golden cross signal is formed, and these stocks are rising well!
Ticker Name
Percentage Change
Inclusion Date